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.2012.04.Abstract Background: Spinal anesthesia is commonly associated with shivering. The aim of this
study was to compare the efﬁcacy of i.v. hydrocortisone with i.v. low dose ketamine or placebo
for prevention of shivering during spinal anesthesia.
Method: In this prospective, randomized, double-blind study, 90 female patients ASA I–II age
30–60 years old, undergoing posterior vaginal repair surgeries under spinal anesthesia with 3 ml
heavy bupivacaine 0.5% (15 mg), patients were randomly allocated into one of three groups,
(Group S, n= 30) (control) received saline, (Group K, n= 30) received ketamine 0.25 mg kg1
or (Group H, n= 30) received hydrocortisone 2 mg kg1, the drugs were given i.v. just after spinal
anesthesia with recording of vital signs, and core temperature every 15 min intraoperative and every
10 min in recovery room. The incidence and intensity of shivering, number of patients received
meperidine, sensory level, motor block grade, and side effects (hypotension, hypertension, tachycar-
dia, nausea and vomiting, sedation and hallucinations) were also recorded.
Results: Incidence of shivering were signiﬁcantly reduced in k and H groups being 20% and 23.3%
respectively compared to S group (p< 0.05). Patients received meperidine to control shivering were
signiﬁcantly low in Groups K and H compared to group S (p< 0.05), with no difference between
Groups K and H.artment of Anesthesia, Cairo
532627.
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218 A.A. Elmawgood et al.Conclusions: The prophylactic administration of low dose ketamine (0.25 mg kg1) and hydrocor-
tisone (2 mg kg1) were comparable in reducing the incidence of shivering and both had signiﬁcant
antishivering effect compared to placebo, in female patients under spinal anesthesia for posterior
vaginal repair surgeries.
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Shivering is a common problem during spinal anesthesia be-
cause of hypothermia that lowers the threshold for shivering
which induce tachycardia, hypertension, and increase oxygen
consumption by 400–500% [1]. Also, it interferes with ECG
and blood pressure monitoring [2]. Hypothermia under spinal
anesthesia is due to core to peripheral redistribution of heat,
loss of vasoconstriction below the level of the block with in-
crease of heat loss from body surfaces, and altered thermoreg-
ulation with decrease in shivering thresholds [3].
A high level of spinal block is known to decrease the core
temperature, the core temperature decreases by 0.15 C, for
each dermatome increase in block level [1].
Many drugs have been used for prevention of shivering
including opioids meperidine; the non-opioid analgesic trama-
dol; the 5-HT3 antagonists ondansetron; the cholinomimetic
agent physostigmine; alpha 2 adrenergic agonist clonidine [3].
Ketamine, a competitive N-methyl D-aspartate (NMDA)
receptor antagonist, which has been shown to inhibit postop-
erative shivering in many reports [4–7].
Hydrocortisone, a glucocorticoid member, which has been
found to be effective in the prevention of postoperative shiver-
ing in the study of Pawar et al. [8], may be through affecting
the protein, fat, carbohydrate, and purine metabolism, and a
direct calorigenic effect.
To our knowledge, there is no study comparing hydrocorti-
sone with ketamine as a prophylactic antishivering agent. This
prospective, randomized, double-blind, placebo controlled
study was designed to compare i.v. hydrocortisone and i.v.
low dose ketamine for the prevention of shivering in female pa-
tients who underwent posterior vaginal repair surgeries under
spinal anesthesia.
2. Method
After approval of the local ethical committee, a written in-
formed consent obtained from 90 female patients ASA I and
II aged 30–60 years old, planned for posterior vaginal repair
surgeries under spinal anesthesia in Beni Sueif university hos-
pital from September 2011 to February 2012.
Patients were excluded from the study if they had history of
convulsions, hypertension, coronary artery disease, thyroid
dysfunction, diabetes, peptic ulcer, or on prolonged steroid
therapy, those with known allergy to amide local anesthetic
or to the study drugs, expected blood transfusion during sur-
gery or any contraindication to regional anesthesia (e.g. local
infection, coagulation abnormality, tight valvular heart lesion
or patient refusal) or BMI > 30 or an initial body tempera-
ture >38 C or <36 C.
The study protocol was explained to each patient during the
preoperative visit. No premedication was given to the patients.On arrival to the operating theatre, the patients were put in the
induction room where 18 G intravenous cannula was inserted
and IV warmed crystalloid ﬂuids (37 C) using level 1 hot
ﬂuid warmer (Rockland, MA, USA) was given at a rate of
10 ml kg1 over 30 min before spinal anesthesia then the rate
was reduced to 6 ml kg1 h1.
The patients were randomly divided using closed envelope
technique for randomization to one of three groups: control
group (Group S, n= 30) received saline, (Group K, n= 30)
received ketamine 0.25 mg kg1 or (Group H, n= 30) received
hydrocortisone 2 mg kg1.
The studied drugs were diluted in 5 ml coded syringes and
the normal saline and given as an i.v. bolus just after intrathe-
cal injection, by an anesthesiologist who was unaware to the
drugs given.
With adjustment of the temperature in operating room at
22 C, the patients were shifted to the operating room where
the monitor was attached to the patients to take preoperative
readings of heart rate, non-invasive arterial blood pressure,
Spo2, and tympanic membrane temperature using FirstTemp
Genius Model 3000 (Sherwood Medical Company, St. Louis,
UK).
Spinal anesthesia was performed under strict aseptic tech-
nique in the sitting position, at L3–L4 or L4–L5 space, with
3 ml heavy bupivacaine 0.5% (15 mg), and the patients were
put in the supine position, supplemented with oxygen
4 L/min by face mask, covered with surgical drapes but not
warmed actively, and monitored with ECG (lead II and V with
ST segment analysis), pulse oximetry, and non-invasive arterial
blood pressure measured every 5 min, and core temperature
were monitored.
At the end of surgery, the patients were shifted to the recov-
ery room, where patients were monitored, covered with one
cotton blanket receiving supplemental oxygen (4 L/min) by
facemask with adjustment of the recovery room temperature
at 22 C.
The following parameters were evaluated in all patients by
an anesthesiologist unaware of the study drugs:
1. Patient characteristics and operation time.
2. Core temperature (tympanic membrane temperature)
before and immediately after the completion of intra-
thecal injection and every 15 min after spinal anesthesia
and every 10 min in the recovery room.
3. Shivering intensity was graded by using a ﬁve-point
scale that was used in the study of Honarmand and Saf-
avi [3]: (Grade 0: none; Grade 1: one or more areas of
piloerection but without visible muscular activity;
Grade 2: visible muscular activity conﬁned to one mus-
cle group; Grade 3: same as Grade 2 but in more than
one muscle group; and Grade 4: gross muscular activity
involving the entire body). If shivering gradesP 3 was
Table 2 Incidence and severity of shivering and number of
patients received meperidine.
Variables Group S
(n= 30)
Group K
(n= 30)
Group H (n= 30)
* *
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one of the studied drugs, the patients were treated with
i.v. meperidine 25 mg or using a heating blankets (Bair
Hugger warming unit, Arizant Healthcare Inc., USA)
in sedated patients.
4. The incidence of shivering.
5. Number of patients requiring meperidine.
6. Sensory level was assessed by loss of cold perception to
ice 5 min after the completion of spinal anesthesia.
7. Motor block was evaluated by Bromage motor scale
[9]: (1, unable to move feet; 2, able to move feet only;
3, just able to move knees; and 4, full ﬂexion of knees
and feet) 5 min after the completion of spinal
anesthesia.
8. Heart rate, mean arterial blood pressure, and periphe-
ral oxygen saturation recorded (intraoperatively before
spinal anesthesia and every 15 min after spinal anesthe-
sia, and every 10 min in the recovery room).
9. Side effects:
– nausea and vomiting (treated with metoclopramide
10 mg i.v.),
– hypotension (decrease in MAP> 20% from preopera-
tive reading and was treated by i.v. ﬂuids and ephedrine
6 mg i.v.),
– hypertension (increase in MAP > 20% from preopera-
tive reading),
– tachycardia (increase in HR> 20% from preoperative
reading,
– hallucination (false sensory experience),
– sedation (graded on a ﬁve-point scale: (1) fully awake
and oriented; (2) drowsy; (3) eyes closed, arousable to
command; (4) eyes closed, arousable to physical stimu-
lation; and (5) eyes closed, unrousable to physical stim-
ulation). [10]
3. Statistical analysis
We calculated the sample size of 30 patients in each group
using the programme of Biostatics version 3.01 based on the
data from previous studies that found the shivering incidence
was 40–65% and we took the incidence of 45% in the control
group and 40% difference between control and treated groups
with the a-error level was ﬁxed at 0.05 and the power was set at
90%. Data values are presented as means (SD), median (range)
or number (percentage). Parametric data were analyzed byTable 1 Patient characteristics and operative data.
Variables Group S
(n= 30)
Group K
(n= 30)
Group H
(n= 30)
Age (years) 46(14) 46(14) 44(14)
Weight (kg) 79(9) 80(8) 81(8)
Height (cm) 168(6) 169(6) 168(6)
ASA physical status (I/II) 12/18 13/17 11/19
Operation time (min) 58(3) 58(4) 59(3)
Group S: Saline group, Group K: ketamine group, Group H:
hydrocortisone group.
Data presented as mean (SD) or number.
No signiﬁcant differences among the studied groups.using one way ANOVA and Student’s paired t-test where
appropriate. Nonparametric data were analyzed by using the
Kruskal–Wallis test. A value of P < 0.05 was considered sig-
niﬁcant. All statistical analysis was performed using Microsoft
Excel.
4. Results
There were no signiﬁcant differences among the three groups
regarding age, weight, height, ASA grade, and operation time
(Table 1).
Incidence of shivering was signiﬁcantly reduced in K and H
groups being 20% and 23.3% respectively, compared to S group
being 60% (p< 0.05). Grade 0 shivering was signiﬁcantly high
inGroupsK andH compared to group S (p< 0.05), with no dif-
ference between Groups K and H. Grade 3 and 4 shivering was
signiﬁcantly low in Groups K and H compared to group S
(p< 0.05), with no difference between Groups K and H.
Patients received meperidine were signiﬁcantly low in Groups
K and H compared to Group S (p< 0.05), with no difference
between Groups K and H. (Table 2).
Core temperature recorded every 15 min intraoperative in
all patients in the three groups decreased in comparison to pre-
operative reading, these decrease were statistically insigniﬁ-
cant. The decrease in temperature was more in H and S
groups than in K group, but the decrease was statistically
insigniﬁcant at every measurement between the three groups
(Table 3).
There were no signiﬁcant differences in hemodynamic
changes (HR and MAp) and peripheral O2 saturation among
the three groups at different times of recording (Table 4).
There were no signiﬁcant differences in sensory level and
motor block grade among the three groups. (Table 5).
Sedation was seen in all patients in K group (100%), 18
cases of them were of Grade 2 and 12 cases were of Grade 3,
without sedation was recorded in H and S groups. There were
no signiﬁcant differences among the three groups regarding
hallucination, hypotension, hypertension and nausea and vom-
iting. (Table 6).Patients
developed
shivering (n)
18 (60) 6 (20) 7 (23.3)
Grades of shivering
Grade 0 12 (40) 24 (80)* 23 (76.6)*
Grade 1 3(10) 3(10) 3(10)
Grade 2 3(10) 2 (6.6) 2 (6.6)
Grade 3 7 (23.3) 1 (3.3)* 1 (3.3)*
Grade 4 5(16.7) 0 (0)* 1 (3.3)*
Number of
patients received
meperidine(n)
12 (40) 0 (0)* 2 (6.6)*
Group S: Saline group, Group K: ketamine group, Group H:
hydrocortisone group.
Data presented as number (percentage).
* Signiﬁcant difference (p< 0.05) Compared to Group S.
Table 3 Core temperature.
Temperature Group S (n= 30) Group K (n= 30) Group H
(n= 30)
Preoperative 36.7(0.1) 36.7(0.1) 36.8(0.13)
Intraoperative
T0 36.6(0.1) 36.7(0.1) 36.6(0.1)
T15 36.1(0.1) 36.4(0.1) 36 (0.1)
T30 35.8 (0.1) 36.2(0.1) 35.9(0.2)
T45 35.6(0.1) 36.1(0.1) 35.6(0.1)
T60 35.4(0.1) 35.9(0.1) 35.4(0.1)
In recovery room
T10 35.5(0.1) 35.7(0.1) 35.6(0.1)
T20 35.6(0.1) 35.6(0.1) 35.6(0.1)
T30 35.5(0.1) 35.6(0.1) 35.6(0.1)
Group S: Saline group, Group K: ketamine group, Group H:
hydrocortisone group.
Data presented as mean (SD), T0: immediately after spinal anes-
thesia, T15: 15 min after spinal anesthesia, T30: 30 min after spinal
anesthesia, T45: 45 min after spinal anesthesia, T60: 60 min after
spinal anesthesia, T10: 10 min in recovery, T20: 20 min in recovery,
T30: 30 min in recovery.
No signiﬁcant differences among the studied groups.
No signiﬁcant differences compared to preoperative reading.
Table 5 Sensory level and motor block grade.
Variables Group S
(n= 30)
Group K
(n= 30)
Group H
(n= 30)
Sensory level(dermatome) T8(T6  T10) T8(T6  T8) T8(T6  T10)
Motor block grade 2(1–2) 1(1–2) 2(1–2)
Group S: Saline group, Group K: ketamine group, Group H:
hydrocortisone group.
Data presented as median (range).
No signiﬁcant differences among the studied groups.
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In this study, our results indicate that i.v. hydrocortisone 2 mg/
kg was effective as iv ketamine 0.25 mg/kg in reducing the inci-
dence and intensity of shivering during spinal anesthesia com-
pared to control group with advantage of hydrocortisone over
ketamine as being not associated with sedation.
In this study, the incidence of shivering in hydrocortisone
group was 23.3% compared to 60% in control group. our re-
sults are in agreement with the studies done by Pawar et al. [8]
who reported that hydrocortisone (1–2 mg kg1 iv) was effec-
tive in prevention of postoperative shivering after knee
arthroscopy under general anesthesia where the incidence ofTable 4 Hemodynamic changes and peripheral O2 saturation.
Time Group S
(n= 30)
Group K
(n= 30
HR MAP Spo2 HR
Intraoperative
T0 79(6) 95(3) 97(1) 79(5)
T15 78(6) 91(2) 98(1) 77(5)
T30 76(4) 89(2) 99(1) 75(4)
T45 75(3) 91(3) 98(1) 73(4)
T60 74(6) 88(2) 99(1) 72(4)
In recovery room
T10 69(6) 88(2) 98(1) 73(2)
T20 71(3) 89(2) 98(1) 73(2)
T30 72(3) 91(3) 99(1) 68(5)
Group S: Saline group, Group K: ketamine group, Group H: hydrocort
Data presented as mean (SD), HR: heart rate, MAP: mean arterial press
anesthesia, T15: 15 min after spinal anesthesia, T30: 30 min after spinal an
anesthesia, T10: 10 min in recovery, T20: 20 min in recovery, T30: 30 mi
No signiﬁcant differences among the studied groups.shivering was 20% and 32% with hydrocortisone 2 mgÆkg1
and 1 mgÆkg1 respectively compared to 60% in control group
and Qioa et al. [11] showed that hydrocortisone 2 mg kg1 iv
was effective in treating post-spinal anesthesia shivering in cae-
sarean section. The mechanism of hydrocortisone prevention
of shivering is unclear. It could be that corticosteroids have
an anabolic effect or through alterations in thyroid hormone
metabolism or nitric oxide synthase activity [8].
In this study the incidence of shivering in ketamine group
was 20% compared to 60% in control group. This is in consis-
tence with many studies that reported the effectiveness of ket-
amine in prevention of postoperative shivering, Norouzi et al.
[4] reported that ketamine 0.25 mg kg1 and 0.5 mg kg1 was a
good prophylactic drug for prevention of postanesthetic shiv-
ering, Shakya et al. [5] concluded that low dose ketamine
0.25 mgÆkg1 compared with ondansetrone 4 mg was effective
in prevention of shivering in lower abdominal surgery under
spinal anesthesia, Dal et al. [6] found that ketamine
0.5 mg kg1 iv was effective like pethedine 20 mg in prevention
of the postoperative shivering after general anesthesia and
Kose et al. [7] found that iv ketamine 0.5 and 0.75 mg kg1
iv ketamine was effective as meperidine 25 mg for the treat-
ment of postoperative shivering. Ketamine prevents shivering
by non-shivering thermogenesis at the level of the hypothala-
mus or the beta adrenergic action of nor epinephrine [3]. Be-
cause of all patients in ketamine group showed a degree of)
Group H
(n= 30)
MAP Spo2 HR MAP Spo2
94(2) 96(2) 78(5) 95(3) 97(1)
89(3) 98(1) 78(6) 88(3) 98(1)
85(3) 99(1) 75(5) 87(2) 99(1)
84(3) 99(1) 73(3) 88(2) 99(1)
89(2) 98(1) 75(3) 89(2) 98(1)
88(2) 98(1) 70(3) 85(3) 98(1)
89(2) 98(1) 69(5) 84(3) 99(1)
90(2) 99(1) 68(6) 89(2) 99(1)
isone group.
ure, Spo2: peripheral oxygen saturation,T0: immediately after spinal
esthesia, T45: 45 min after spinal anesthesia, T60: 60 min after spinal
n in recovery.
Table 6 Side effects.
Variables Group S
(n= 30)
Group K
(n= 30)
Group H
(n= 30)
Nausea and vomiting 0(0) 0(0) 0(0)
Hallucination 0(0) 0(0) 0(0)
Hypotension 0(0) 0(0) 0(0)
Hypertension 0(0) 0(0) 0(0)
Sedation
Grade 1 0(0) 0(0) 0(0)
Grade 2 0(0) 18(60)* 0(0)
Grade 3 0(0) 12(40)* 0(0)
Grade 4 0(0) 0(0) 0(0)
Grade 5 0(0) 0(0) 0(0)
Group S: Saline group, Group K: ketamine group, Group H:
hydrocortisone group.
Data presented as number (percentage).
* Signiﬁcant difference (p< 0.05) compared to other two groups.
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were treated with heating blankets, not with i.v. meperidine.
In this study the core temperature measured through tym-
panic membrane decreased during intraoperative period in the
three groups compared to preoperative reading. The decrease
in temperature was clinically signiﬁcant but statistically insignif-
icant. The hypothermia during spinal anesthesia can be
explained by heat redistribution from core to periphery, vasodi-
latation with heat loss and inhibition of thermoregulation. The
decrease in temperature was less signiﬁcant in ketamine group
than hydrocortisone and saline groups; this may be due to vaso-
constrictive effect of ketamine. This is in consistence with the
study of Shakya et al. [5] who found decrease of temperature
in ketamine (0.25 mg kg1) groupwas less than in ondansetrone
and saline groups during spinal anesthesia. In the study done by
Sagir et al. [12], the decrease of core temperature was more in
control group than ketamine (0.5 mg kg1) group. However,
Pawar et al. [8], found the decrease of core temperature during
anesthesia was similar between hydrocortisone (1–2 mg kg1)
group and saline group during knee arthroscopy.
The hemodynamic parameters (heart rate and mean arterial
pressure) in our study were comparable among the three
groups. This is in agreement with the studies of Shakya et al.
[5], Dal et al. [6], and Sagir et al. [12] who found no hemody-
namic changes associated with ketamine, also, no hemody-
namic changes associated with hydrocortisone (single dose)
in the studies done by Pawar et al. [8], Keh et al. [13], and
Jules-Elysee et al. [14].
In this study all patients in ketamine group developed seda-
tion, 18 cases of them were of Grade 2 and 12 cases were of
Grade 3 without hallucination. This is in consistent with the
result of Shakya et al. [5], who found sedation in 95% of pa-
tients without hallucination with ketamine 0.25 mg kg1.
Hypotension was not recorded in this study because of ﬂuid
preloading before spinal anesthesia. Also, nausea and vomiting
were not observed in any of patients in this study, although it
is a known side effect of ketamine, may be because of low dose
ketamine 0.25 mg kg1 used in this study, this is in agreement
with Shakya et al. [5].It is found that ketamine 0.5 mg kg1 iv was effective like
pethedine 20 mg in prevention of the postoperative shivering
after general anesthesia [6], however we did not ﬁnd a study
comparing hydrocortisone with pethedine.
In conclusion, the prophylactic administration of low dose
ketamine (0.25 mg kg1) and hydrocortisone (2 mg kg1) were
comparable in reducing the incidence of shivering and both
had signiﬁcant antishivering effect compared to placebo, in
female patients under spinal anesthesia for posterior vaginal
repair surgeries.
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